Article Text

See original article:

Download PDFPDF
The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies
  1. P A Barber1,
  2. A M Demchuk1,
  3. M D Hill1,2,
  4. J H Warwick Pexman1,
  5. M E Hudon1,3,
  6. R Frayne1,4,
  7. A M Buchan1
  1. 1Calgary Stroke Program, Department of Clinical Neuroscience, Seaman Family Magnetic Research Centre, 1403-29 St. NW, Calgary, AB, Canada
  2. 2Department of Medicine and Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada
  3. 3Department of Clinical Radiology, University of Calgary, Calgary, AB, Canada
  4. 4Department of Radiology, University of Calgary, Calgary, AB, Canada
  1. Correspondence to:
 P A Barber Assistant Professor
 Department of Clinical Neurosciences, University of Calgary, Institute for Biodiagnostics (West), Room 153, 3330 Hospital Drive, Calgary, Canada AB T2N 4N1; pabarberucalgary.ca

Abstract

Objectives: In this study we define the probability of vascular abnormality in the middle cerebral artery (MCA) territory according to the extent of ischaemic change seen using computed tomography (CT). We assessed the sensitivity and specificity of the hyperdense middle cerebral artery (HMCA) and the “dot” sign using magnetic resonance angiography (MRA).

Methods: Patients presenting with ischaemic stroke had a CT scan (<6 h) prior to MRI (<7 h). A quantitative CT scoring system (ASPECTS) was applied to CT and diffusion weighted images (DWI) at baseline and follow up (24 h) by five independent observers. The presence of HMCA and the MCA “dot” sign was also evaluated. An expert reader assessed the 3D time of flight (TOF) MRA in the anterior circulation for areas of decreased vascular signal in the MCA territory, with an absent signal taken to represent severely reduced or absent flow.

Results: A total of 100 consecutive patients had baseline CT and MR scans. The median NIHSS was 9. The median CT ASPECTS was 8 and equalled the median DWI ASPECTS. There were a total of 10 HMCA and 19 MCA “dot” signs, with four patients having both HMCA and “dot” signs. A total of 47 MRA flow signal abnormalities were observed in the anterior circulation.

Conclusions: In the absence of accessible neurovascular imaging, the extent of CT ischaemia (ASPECTS) is a strong predictor of vascular occlusion. The CT hyperdense artery signs have a high positive predictive value but low negative predictive value.

  • ACAs, anterior cerebral artery
  • ASPECTS, Alberta Stroke Program Early CT Score
  • BA, basilar artery
  • CT, computed tomography
  • DWI, diffusion weighted imaging
  • FLAIR, fluid attenuated inversion recovery
  • HMCA, hyperdense MCA
  • ICA, internal carotid artery
  • MCA, middle cerebral artery
  • MRA, magnetic resonance angiography
  • mRS, modified Rankin scale
  • NIHSS, National Institute of Health Stroke Scale
  • PCA, posterior cerebral artery
  • PROACT-II, ProLyse for Acute Cerebral Thromboembolism trial
  • tPA, tissue plasminogen activator
  • acute stroke
  • computed tomography
  • magnetic resonance angiography
  • vascular occlusion

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • This study was supported by the Alberta Foundation for Health Research. Dr Barber was supported by the Canadian Institute of Health Research, the Heart and Stroke Foundation of Canada, and the Alberta Heritage Foundation for Medical Research. Dr Hill was supported by the Heart and Stroke Foundation of Alberta, NWT, Nunavut and the Canadian Institutes for Health Research. Dr Demchuk was supported by the Alberta Heritage Foundation for Medical Research and the Canadian Institute of Health Research. Dr Frayne was supported by Heart and Stroke Foundation of Canada and the Alberta Heritage Foundation for Medical Research. Dr Buchan was supported by the Heart and Stroke Foundation of Canada, and the Alberta Heritage Foundation for Medical Research.

  • Competing interests: none declared

Linked Articles

  • Correction
    BMJ Publishing Group Ltd